tiprankstipranks
Iqvia downgraded to Neutral at Guggenheim on valuation
PremiumThe FlyIqvia downgraded to Neutral at Guggenheim on valuation
2M ago
Iqvia price target raised to $265 from $255 at Evercore ISI
PremiumThe Fly
Iqvia price target raised to $265 from $255 at Evercore ISI
2M ago
Iqvia price target raised to $270 from $239 at TD Cowen
PremiumThe Fly
Iqvia price target raised to $270 from $239 at TD Cowen
2M ago
Iqvia sees FY24 adjusted EPS $10.95-$11.25, consensus $11.07
PremiumThe FlyIqvia sees FY24 adjusted EPS $10.95-$11.25, consensus $11.07
2M ago
Iqvia reports Q4 adjusted EPS $2.84, consensus $2.82
PremiumThe Fly
Iqvia reports Q4 adjusted EPS $2.84, consensus $2.82
2M ago
Early notable gainers among liquid option names on February 14th
PremiumThe Fly
Early notable gainers among liquid option names on February 14th
2M ago
AbbVie price target raised to $172 from $165 at UBS
PremiumThe FlyAbbVie price target raised to $172 from $165 at UBS
2M ago
Iqvia price target raised to $260 from $215 at Barclays
PremiumThe Fly
Iqvia price target raised to $260 from $215 at Barclays
3M ago
Iqvia price target raised to $226 from $221 at Baird
PremiumThe Fly
Iqvia price target raised to $226 from $221 at Baird
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100